Synthesis,characterization and biological studies of alkenyl‐substituted titanocene(IV) carboxylate complexes

The carboxylate compounds [Ti(η⁵‐C₅H₅)(η⁵‐C₅H₄{CMe₂(CH₂CH₂CH?CH₂)})(O₂CCH₂SXyl)₂] (2; Xyl = 3,5‐Me₂C₆H₃) and [Ti(η⁵‐C₅H₅)(η⁵‐C₅H₄{CMe₂(CH₂CH₂CH?CH₂)})(O₂CCH₂SMesl)₂] (3; Mes 1 = 2,4,6‐Me₃C₆H₂) were synthesized by the reaction of [Ti(η⁵‐C₅H₅)(η⁵‐C₅H₄{CMe₂(CH₂CH₂CH?CH₂)})Cl₂] (1) with 2 equivalents of xylylthioacetic acid or mesitylthioacetic acid, respectively. Compounds 2 and 3 were characterized by spectroscopic methods. The cytotoxic activity of 1–3 was tested against human tumor cell lines from four different histogenic origins—8505C (anaplastic thyroid cancer), DLD‐1 (colon cancer) and the cisplatin sensitive A253 (head and neck cancer) and A549 (lung carcinoma)—and compared with those of the reference complex [Ti(η⁵‐C₅H₅)₂Cl₂] (R1) and cisplatin. Surprisingly, the cytotoxic activities of the carboxylate derivatives were lower than those of their corresponding dichloride analogue (1). However, complexes 1–3 were more active than titanocene dichloride against all the studied cells with the exception of complex 2 against A253 and A549 cell lines. DNA‐interaction tests were also carried out. Solutions of all the studied complexes were treated with different concentrations of fish sperm DNA, observing modifications of the UV spectra with intrinsic binding constants of 2.99 × 10⁵, 2.45 × 10⁵, and 2.35 × 10⁵ M ^?1 for 1–3. Structural studies based on density functional theory calculations of 2 and 3 were also carried out. Copyright © 2010 John Wiley & Sons, Ltd.     

Synthesis and characterization of dinuclear pyrazolato bridged platinum(IV) complexes

Reactions of [PtMe₃(OCMe₂)₃](BF₄) and [(PtMe₃I)₄] with pyrazole (pzH) afforded mononuclear pyrazole platinum(IV) complexes [PtMe₃(pzH)₃](BF₄) (1) and [PtMe₃I(pzH)₂] (2), respectively. The formation of dinuclear pyrazolato bridged platinum(IV) complexes (PPN)[(PtMe₃)₂(μ-pz)₃] (3), (PPN)[(PtMe₃)₂(μ-I)(μ-pz)₂] · 1/2Et₂O (4) and [K(18C6)][(PtMe₃)₂(μ-I)(μ-pz)₂] (5) was achieved by the reaction of each 1 and 2 with [PtMe₃(OCMe₂)₃](BF₄) in the presence of KOAc followed by reaction with (PPN)Cl (PPN⁺ = bis(triphenylphosphine)iminium cation) and 18C6, respectively. The reaction of complex 4 with AgO₂CCF₃ followed by addition of RSR′ (R/R′ = Me/Me, Me/Ph) resulted in the formation of complexes [(PtMe₃)₂(μ-pz)₂(μ-RSR′)] (R/R′ = Me/Me, 6; Me/Ph, 7). All complexes were characterized unambiguously by microanalysis and NMR (¹H, ¹³C) spectroscopic investigations. Additionally, crystal structures of complexes 3 and 4 as well as DFT calculation are presented. Furthermore, in vitro studies on the anti-proliferative activity of complexes 2 and 5 were carried out.     

Anticancer drugs based on alkenyl and boryl substituted titanocene complexes

The alkenyl-substituted titanocene complex [Ti(η⁵-C₅H₅)(η⁵-C₅H₄{CMe₂(CH₂CH₂CHCH₂)})Cl₂] (1) has been synthesized and characterized using traditional methods. The reaction of 1 with 9-BBN gave the boryl substituted complex [Ti(η⁵-C₅H₅)(η⁵-C₅H₄{CMe₂(CH₂CH₂CH₂CH₂BC₈H₁₄)})Cl₂] (2). The cytotoxic activity of 1 and 2 was tested against tumour cell lines human adenocarcinoma HeLa, human myelogenous leukemia K562, human malignant melanoma Fem-x, human breast carcinoma MDA-MB-361 and normal immunocompetent cells peripheral blood mononuclear cells PBMC and compared with those of the reference complexes [Ti(η⁵-C₅H₅)₂Cl₂] (R1), [Ti(η⁵-C₅H₄Me)₂Cl₂] (R2) and [Ti(η⁵-C₅H₅)(η⁵-C₅H₄SiMe₃)Cl₂] (R3). Complex 1 showed higher cytotoxic activities on HeLa, Fem-x and K562 (IC₅₀ values from 96.6 ± 3.4 to 149.2 ± 2.9 μM) than the reference complexes R1, R2 and R3 which presented IC₅₀ values from 173.3 ± 6.0 to >200 μM. On the other hand, boryl substituted complex 2, present slightly lower cytotoxic activities than 1 on HeLa, Fem-x and K562 (IC₅₀ values from 155.6 ± 5.5 to 167.9 ± 4.2 μM). However, 2 was the most active of the studied complexes against MDA-MB-361 (IC₅₀ value of 161.1 ± 0.1 μM). Structural studies based on DFT calculations of 1 and 2 have also been carried out in order to gain a possible insight into the relationship between metal complex structure and cytotoxicity.     

Domestic petroleum-related expertise utilization and Nigeria's oil industry survival: A multicriteria decision analysis

Despite Nigeria's current economic crisis and the need to remove control structures which were originally designed to protect national interest so as to attract foreign investment in upstream activities of its oil sector, the notion of an indigenously controlled oil sector is still alive in the country. The current paper utilizes a multiperiod goal programming model to examine the effect the enforcement of Nigeria's Petroleum Decree on the utilization of domestic petroleum-related expertise would have on the survival of the multinational oil companies and, therefore, of the oil industry. The results indicate that there are some benefits to the nation in enforcing the Decree, but that to do so now will trigger a chain of events that will culminate in the demise of the oil industry. The results also highlight the danger in using legislation to regulate strategic industries and the role operational researchers can play in public policy design and decisions in the future.     

Properties of nanocrystalline electrodeposited CoFeP alloy with low phosphorus content

CoFe and low phosphorus containing (<4 at.%) CoFeP alloy films were electrodeposited from NaH₂PO₂ containing solutions at pH 4 on copper substrates under galvanostatic conditions. At the low phosphorus composition, nanocrystalline CoFeP alloy films are formed. The structure, composition and morphology of the thin films were studied using X-ray diffraction, energy dispersive spectroscopy and atomic force microscopy. The magnetic properties of the film were studied using superconducting quantum interference device magnetometer. The thin film performance features were explained on the basis of microstructural features developed during deposition. Whereas the electrodeposited CoFe alloy thin film exhibited mixed hcp and fcc phase structure in the absence of phosphorus, the low phosphorus containing thin film exhibited an increasing mixed bcc and hcp phase structure as its phosphorus content increases, showing modification in the grain size morphology and magnetic properties. In addition to applied current, the amount of P co-deposited in CoFeP alloy depends on the concentration of NaH₂PO₂ source in the bath. Qualitative analysis of the Tafel slope of CoFe and CoFeP deposition suggests that the presence of P in the CoFe deposit does not affect the mechanism of anomalous deposition of Co and Fe, thereby suggesting that CoFeP deposition is anomalous.     

Structural and optical properties of cadmium magnesium zinc oxide (CdMgZnO) nanoparticles synthesized by sol–gel method

Nanoparticles of ${\mathrm{Cd}}_x{\mathrm{Mg}}_{0.12?x}{\mathrm{Zn}}_{0.88}\mathrm{O}$ $(0\le x\le 0.02)$ were synthesized by a simple sol gel route with the combination of chelating agents. Effect of cadmium on the phase, structural, morphological and optical properties of the synthesized nanoparticles has been studied and reported by using X-ray diffraction (XRD), transmission electron microscopy (TEM), scanning electron microscopy (SEM), energy dispersive X-ray (EDX), Fourier transform infrared spectroscopy (FTIR) and UV–Vis diffuse reflectance spectroscopy (UV–vis DRS). The crystal size, lattice parameters, unit cell volume, X-ray density, inter-planar distances and bond length were obtained and analyzed from the XRD data. The X-ray analysis reveals the formation of a single phase with a hexagonal wurtzite structure, where an increase of the cell volume was achieved as the Cd content was increased as well. Synthesized nanoparticle were nearly spherical at nano-size regime and are loosely agglomerated as observed from the SEM analysis. EDX spectra of the composition confirmed the appropriate stoichiometric ratio. A fundamental absorption peak centered at 375 nm was observed from the UV–visible absorption spectra which shifted towards a higher wavelength correlating the narrowing of the energy band gap due to increase in Cd content. The structural adjustment from the IR spectra confirmed the stretching vibration of Zn–O in the ${\mathrm{Cd}}_x{\mathrm{Mg}}_{0.12?x}{\mathrm{Zn}}_{0.88}\mathrm{O}$ lattice with Cd content.     

Titanium(IV) carboxylate complexes: Synthesis,structural characterization and cytotoxic activity

Four titanium(IV) carboxylate complexes [Ti(η⁵-C₅H₅)₂(O₂CCH₂SMes)₂] (1), [Ti(η⁵-C₅H₄Me)₂(O₂CCH₂SMes)₂] (2), [Ti(η⁵-C₅H₅)(η⁵-C₅H₄SiMe₃)(O₂CCH₂SMes)₂] (3) and [Ti(η⁵-C₅Me₅)(O₂CCH₂SMes)₃] (4; Mes = 2,4,6-Me₃C₆H₂) have been synthesised by the reaction of the corresponding titanium derivatives [Ti(η⁵-C₅H₅)₂Cl₂], [Ti(η⁵-C₅H₄Me)₂Cl₂], [Ti(η⁵-C₅H₅)(η⁵-C₅H₄SiMe₃)Cl₂] and [Ti(η⁵-C₅Me₅)Cl₃] and two (for 1–3) or three (for 4) equivalents of mesitylthioacetic acid. Complexes 1–4 have been characterized by spectroscopic methods and the molecular structure of the complexes 1, 2 and 4 have been determined by X-ray diffraction studies. The cytotoxic activity of 1–4 was tested against tumor cell lines human adenocarcinoma HeLa, human myelogenous leukemia K562, human malignant melanoma Fem-x, and normal immunocompetent cells, that is peripheral blood mononuclear cells PBMC and compared with those of the reference complexes [Ti(η⁵-C₅H₅)₂Cl₂] (R1), [Ti(η⁵-C₅H₄Me)₂Cl₂] (R2), [Ti(η⁵-C₅H₅)(η⁵-C₅H₄SiMe₃)Cl₂] (R3) and cisplatin. In all cases, the cytotoxic activity of the carboxylate derivatives was higher than that of their corresponding dichloride analogues, indicating a positive effect of the carboxylato ligand on the final anticancer activity. Complexes 1–4 are more active against K562 (IC₅₀ values from 72.2 to 87.9 μM) than against HeLa (IC₅₀ values from 107.2 to 142.2 μM) and Fem-x cells (IC₅₀ values from 90.2 to 191.4 μM).     

Electrospray mass spectrometric studies of a potential antitumor drug and its analogous platinum(II) and platinum(IV) complexes with the ethylenediamine-N,N′-di-3-propanoato ligand and its dibutyl ester

Abstract  The electrospray mass spectrometric (ESI–MS) behavior of the complexes trans-dichloro(ethylenediamine-N,N′-di-3-propionato)platinum(IV), trans-dibromo(ethylenediamine-N,N′-di-3-propionato)platinum(IV), dichloro(ethylenediamine-N,N′-di-3-propionic acid)platinum(II), tetrachloro(O,O′-di-n-butyl-ethylenediamine-N,N′-di-3-propanoate)platinum(IV), chlorotribromo(O,O′-di-n-butyl-ethylenediamine-N,N′-di-3-propanoate)platinum(IV), and dichloro(O,O′-di-n-butyl-ethylenediamine-N,N′-di-3-propanoate)platinum(II), with the formulae trans-[PtCl₂(eddp)] (1), trans-[PtBr₂(eddp)] (2), [PtCl₂(H₂eddp)] (3), [PtCl₄(Bu₂eddp)] (4), [PtBr₃Cl(Bu₂eddp)] (5), and [PtCl₂(Bu₂eddp)]·H₂O (6), is reported. The deprotonated molecular ions or halide adducts are usually observed. ESI–MS data demonstrate the usefulness of the method for efficient characterization of metal complexes in solution. Graphical Abstract        

A novel alkenyl-substituted ansa-zirconocene complex with dual application as olefin polymerization catalyst and anticancer drug

The alkenyl substituted fulvene compound, (C₅H₄)CMe(CH₂CH₂CHCMe₂) (1), reacts with one equivalent of LiMe to give the lithium derivative Li{C₅H₄(CMe₂CH₂CH₂CHCMe₂)} (2). The reaction of 2 with Me₂Si(C₅Me₄H)Cl gave the ansa-ligand precursor Me₂Si(C₅Me₄H)(C₅H₄(CMe₂CH₂CH₂CHCMe₂)) (3), which after the subsequent reaction with 2 equivalents of LiBuⁿ yielded the dilithium salt Li₂{Me₂Si(C₅Me₄)(C₅H₃(CMe₂CH₂CH₂CHCMe₂))} (4). The alkenyl-substituted zirconocene complex [Zr{Me₂Si(η⁵-C₅Me₄)(η⁵-C₅H₃(CMe₂CH₂CH₂CHCMe₂))}Cl₂] (5) was synthesized by the equimolar reaction of 4 and ZrCl₄. 5 was characterized by spectroscopic methods and by single crystal X-ray diffraction studies. The zirconocene compound 5 has been tested as a catalyst in the polymerization of ethylene at different temperatures and Al:Zr ratios, and also in the co-polymerization of ethylene and 1-octene, observing modest co-monomer incorporations. In addition, the cytotoxic activity of 5 was tested against tumour cell lines 8505C anaplastic thyroid cancer, A253 head and neck tumour, A549 lung carcinoma, A2780 ovarian cancer and DLD-1 colon carcinoma. Complex 5 showed the best cytotoxic activity on A2780 ovarian cancer (IC₅₀ value of 36.8 ± 5.9 μM). This represents the highest reported cytotoxic activity of a zirconocene complex on A2780 ovarian cancer. In addition, the cytotoxic activities of 5, have been compared with those obtained using cisplatin.